Description of the blood test: 

The HHV-6 IgM test is a laboratory study used to detect the acute phase of an infection caused by Human Herpesvirus 6. This virus is widely known as the cause of roseola infantum in children, but in adults, it can lead to more complex conditions, including chronic fatigue syndrome or neurological inflammation. The presence of IgM antibodies indicates that the virus is currently active—either as a new infection or as a reactivation of a dormant virus. This test is a critical indicator for physicians investigating unexplained fevers or sudden neurological symptoms.

What does the analysis represent?

• Purpose: Qualitative detection of IgM class antibodies to identify active HHV-6 replication.

• Primary application: Diagnosis of acute roseola, evaluation of viral triggers for chronic fatigue, and investigation of neurological disorders.

• Performance: High-sensitivity immunological study of venous blood serum.

Recommendations for the test (General)

• Time: Blood collection is recommended in the morning.

• Fasting: A fasting period of 4–8 hours is preferred.

• Rest: Spend 15–30 minutes in a calm state before the procedure.

• Important: HHV-6 is neurotropic, meaning it can affect the nervous system; therefore, detecting its active phase is vital for neurological health assessments.

What can affect the results?

• False-positive results: May occur due to cross-reactivity with other herpesviruses, such as HHV-7 or Cytomegalovirus (CMV).

• Timing: IgM antibodies are transient; if the test is taken too late after the onset of symptoms, the result may be negative.

When to take the test?

• Recommendations: Prescribed for patients with sudden high fever, skin rashes, persistent “brain fog,” or chronic exhaustion.

• Preparation: Standard serological preparation; avoid heavy meals 24 hours before the analysis.

How to interpret the results?

The interpretation of data is the exclusive responsibility of an infectious disease specialist, immunologist, or neurologist. A positive HHV-6 IgM result is a biochemical marker of activity but not a final diagnosis of a specific disease. The physician correlates this with the patient’s symptoms and neurological findings. Only an expert can determine if the viral activity is the cause of current health issues and if antiviral or immunomodulatory therapy is appropriate.

Possible further investigations

• HHV-6 IgG: To determine if this is a primary infection or a reactivation of a long-term carrier state.

• HHV-6 PCR: To measure the viral load and confirm the presence of viral DNA.

• Consultation with a Neurologist: To assess the impact of the virus on cognitive and nerve function.

When does the next step make sense?

Detecting active HHV-6 provides a path forward for those suffering from unexplained fatigue or neurological discomfort. The next step is a specialist consultation to ensure the virus is successfully managed and to protect the long-term health of your nervous system.

👉 If necessary, you can discuss the test results with our specialized — neurologist (Doctors – TAMC).